Trade ESLA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Estrella Immunopharma, Inc. (ESLA) is trading at US$0.66, down 1.99% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$31.98M. Over the past 52 weeks, ESLA has traded between US$0.59 and US$3.15. On Syfe you can trade ESLA with $0 commission and add it to your watchlist.
| Previous close | US$0.67 |
|---|---|
| Market cap | US$31.98M |
| 52-week range | US$0.59 – US$3.15 |
| Volume | 25.93K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
Year: 2023
Estrella Immunopharma's Trial of EB103 to Treat Lymphoma Doses First Patient
Jul 24, 12:50 PM · MT Newswires
Estrella Immunopharma, Inc. (ESLA) stock is trading at US$0.66, -1.99% from the previous close of US$0.67.
The market cap for Estrella Immunopharma, Inc. (ESLA) stock is approximately US$31.98M.
The 52-week high for Estrella Immunopharma, Inc. (ESLA) stock is US$3.15.
The 52-week low for Estrella Immunopharma, Inc. (ESLA) stock is US$0.59.
Estrella Immunopharma, Inc. (ESLA) does not currently pay a dividend.
Stay on top of ESLA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
